Penalty Amount
$1,050,000
Connecticut Attorney General William Tong led a coalition of 45 states and territories seeking court approval for settlements resolving allegations that Ascend Laboratories, Citron Pharma, and Mayne Pharma conspired to inflate prices and limit competition for generic prescription drugs. Ascend agreed to pay $400,000, Mayne agreed to pay $650,000, and Citron’s settlement includes non-monetary terms; the companies also agreed to internal reforms.
Ascend will pay $400,000 and Mayne will pay $650,000 to the states; Citron’s settlement has no monetary terms. Each company agreed to injunctive terms and internal reforms intended to promote fair competition and compliance with antitrust laws.
Review vendor, distributor, customer, and other commercial agreements in the pharmaceutical supply chain for provisions that could facilitate exchange of competitively sensitive pricing, sales, or market-allocation information with competitors. Check antitrust compliance representations, restrictions on sharing nonpublic competitor information, independent pricing and sales decision requirements, audit and cooperation rights, and controls governing trade associations or industry events; privacy-specific clauses are not implicated by the reported allegations.
Entity
Ascend Laboratories, Citron Pharma, and Mayne Pharma
Industry
HealthcareOfficial Press Release
https://portal.ct.gov/ag/press-releases/2026-press-releases/attorney-general-tong-seeks-court-approval-for-settlements-with-ascend-citron-and-mayne
ascend citron and mayne motion for preliminary approval.pdf?
https://portal.ct.gov/-/media/ag/press_releases/2026/ascend-citron-and-mayne-motion-for-preliminary-approval.pdf?rev=e1c7206d58b64ea59a4bb12a15ba4a9a&hash=DC1986FB9E21B6612C4F9347821C4B78
Connecticut Attorney General Enforcement Page
https://portal.ct.gov/AG/Privacy/Privacy-Resources
"three settlements with Ascend Laboratories, Citron Pharma and Mayne Pharma"
"Ascend will pay $400,000 to the states. Mayne will pay $650,000."
"compliance with antitrust laws"
"engaged in a widespread, long-running conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs."
$625K
Connecticut reached a $625,000 settlement with Frontier Communications Parent Inc. over an April 2024 breach in which compromised employee and vendor credentials were used to access internal systems and exfiltrate unencrypted personal information of 58,841 Connecticut residents. The settlement requires Frontier to strengthen its security program, implement specific safeguards and training, and obtain an independent third-party assessment.
$2.6M
Connecticut and New York found that Boston Children’s Health Physicians and its security vendor, XTIUM, failed to use reasonable safeguards, resulting in hackers accessing sensitive personal, medical, and employee information. The companies agreed to pay penalties totaling $2.64 million and implement enhanced cybersecurity measures.
Connecticut joined a coalition of state attorneys general filing a notice in Character Technologies, Inc.’s bankruptcy proceedings, raising concerns about the company’s safety and privacy practices and the sensitive information it holds. The states seek protections for children and consumers if the company’s business or assets are sold or transferred; the filing does not impose a fine or other remedy.
Attorney General William Tong and Consumer Counsel Claire Coleman petitioned PURA to review how Connecticut public utilities use artificial intelligence, citing potential data privacy and cybersecurity risks, algorithmic errors, and misleading outputs. The petition asks PURA to examine utility AI systems, safeguards, vendors, and data security practices; it does not report a finding of violation or an imposed penalty.
$2.0M
Connecticut Attorney General William Tong announced a settlement with RZ Smoke, Inc. over allegations that it distributed and sold high-potency cannabis products without a state license. The stipulated judgment is $2 million, with $375,000 payable to the State and $1.6 million suspended to ensure compliance; the company is barred from specified cannabis activities in Connecticut unless licensed.
$13.7M
Connecticut joined a coalition of states and the federal government in settling allegations that Takeda paid healthcare providers speaker honoraria and provided meals to induce prescriptions of Trintellix, leading to allegedly false claims to government healthcare programs. Takeda agreed to pay $13,670,921 plus accrued interest, with portions allocated to federal and state programs.